-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2024 - identify those at risk for developing CVD who also have a
history of other comorbid conditions (e.g., obesity
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2019.pdf
January 01, 2019 - Final Report, Year 3: CDS Connect
CDS Connect
CDS Connect
Contract Year 3
Final Report
Final Report (Year 3)
CDS Connect
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
Contract No. HHSA290201600001U
Prepared by:
CMS Alliance to Modernize Healthcare (The …
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention_2.pdf
April 01, 2021 - identify those at risk for developing CVD who also have a
history of other comorbid conditions (e.g., obesity
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation_Guide_CDS_Connect_Statin_CVD_Clinician_Facing_0.pdf
September 01, 2022 - identify those at risk for developing CVD who also have a
history of other comorbid conditions (e.g., obesity
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2023_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2023 - identify those at risk for developing CVD who also have a
history of other comorbid conditions (e.g., obesity
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Patient%20Facing%20CDS%20Intervention_Final.pdf
September 01, 2019 - identify those at risk for developing CVD who also have a history of other comorbid
conditions such as obesity
-
cds.ahrq.gov/sites/default/files/cds/artifact/171/Occupational%20Factors%20which%20Impact%20Diabetes,%20%20A%20Final%20Knowledge%20Resource%20Report%20(2015).pdf
January 01, 2015 - This can be exacerbated by obesity and medications use to treat diabetes and its
complications.
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository.xlsx
January 01, 2003 - Hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML Oral Suspension
E66.2 Morbid (severe) obesity
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
January 01, 2003 - Hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML Oral Suspension
E66.2 Morbid (severe) obesity
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
January 01, 2024 - identify those at risk for developing CVD who also have a history of
other comorbid conditions (e.g., obesity
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Patient%20Facing%20CDS%20Intervention_Final_1.pdf
April 01, 2021 - identify
those at risk for developing CVD who also have a history of other comorbid conditions
(e.g., obesity
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/508_2022_CDS_Connect_IG_Statin_CVD_Patient_Facing_final.pdf
January 01, 2022 - identify those at risk for developing CVD who also have a history of
other comorbid conditions (e.g., obesity
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
January 01, 2023 - identify those at risk for developing CVD who also have a history of
other comorbid conditions (e.g., obesity
-
cds.ahrq.gov/sites/default/files/reports/AHRQ_Final_Report_2018.pdf
January 01, 2018 - Management
CDC Structured Event-
Condition-
Action rule
Healthy Weight
Care Assistant
Childhood
Obesity
-
cds.ahrq.gov/cedar/AHRQ_CEDAR_Environmental_Scan_2020_508.pdf
January 01, 2020 - Medicine No No P
(Nuclear Medicine;
Radiation Oncology;
Radiology)
No No
Nursing No No
No No
Obesity